Dr. Imo Joseph Akpan, MD

Dr. Akpan practices at Columbia University Irving Medical Center in New York, New York.

Dr. Akpan's NPI, 1093077208, was assigned on June 13, 2012. Dr. Akpan graduated from University of Illinois College of Medicine - Chicago in 2012. Dr. Akpan holds New York license 300746.

Dr. Akpan's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Akpan's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Akpan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Akpan to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akpan practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Akpan's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Akpan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Akpan's licenses on file in 3 states: New York, Illinois and New Jersey.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT) and purpura and thrombocytopenia among the conditions Dr. Akpan treats.

CMS data shows 320 Medicare services from Dr. Akpan across 5 procedure codes in 2024, for 139 Medicare patients. Medicare paid $22,417 for them.

CMS counts 139 Medicare patients who saw Dr. Akpan in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akpan's median patient age at 48, with 79% women.

In 2024, Dr. Akpan wrote 114 Medicare Part D claims for 33 patients. 57% of them were for generic drugs. CMS names the drug for 67 of them, across 2 drugs with 11 or more claims each, at $32,470 in total drug cost. In 2023, CMS named 83 claims across 3 drugs.

Dr. Akpan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Akpan, published from 2004 to 2025. 2021 was the busiest year, with 4. The most frequent topics are COVID-19, Iron and SARS-CoV-2. Dr. Akpan has published most often in Blood. Dr. Akpan's most frequent co-authors are Nancy C. Andrews, MD, PhD, Michael W. Drazer, MD and Lucy Ann Godley.

CMS Open Payments shows 24 general payments to Dr. Akpan from 3 drug and device companies from 2017 to 2023. Travel and lodging make up the largest share, 46% of the total. Pharmacosmos Therapeutics Inc. paid the most, $32,646.

Dr. Akpan graduated from University of Illinois College of Medicine - Chicago in 2012. Dr. Akpan is a member of ASH, Hemostasis and Thrombosis Research Society and International Society on Thrombosis and Haemostasis.

Dr. Akpan is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.